NCT03702426

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

Comparison of the Efficacy of Granulocyte - Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis - A Randomised Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Institute of Liver and Biliary Sciences, India · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

-Consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with spontaneous bacterial peritonitis will be evaluated

Conditions

• Spontaneous Bacterial Peritonitis

Interventions

Type	Name	Description
DRUG	GMCSF	GMCSF 1.5mcg/Kg
DRUG	Norfloxacin	Tablet Norfloxacin 400 mg

Timeline

• Start date: 2018-07-23
• Primary completion: 2019-07-31
• Completion: 2019-07-31
• First posted: 2018-10-11
• Last updated: 2019-10-24

Locations

1 site across 1 country: India